Canada Infectious Disease Therapeutics Market Size & Outlook
Related Markets
Canada infectious disease therapeutics market highlights
- The Canada infectious disease therapeutics market generated a revenue of USD 7,950.9 million in 2024 and is expected to reach USD 9,418.4 million by 2030.
- The Canada market is expected to grow at a CAGR of 3.8% from 2025 to 2030.
- In terms of segment, viral infections was the largest revenue generating infection type in 2024.
- Parasitic Infections is the most lucrative infection type segment registering the fastest growth during the forecast period.
Infectious disease therapeutics market data book summary
| Market revenue in 2024 | USD 7,950.9 million |
| Market revenue in 2030 | USD 9,418.4 million |
| Growth rate | 3.8% (CAGR from 2025 to 2030) |
| Largest segment | Viral infections |
| Fastest growing segment | Parasitic Infections |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bacterial Infections, Viral Infections, Fungal Infections, Parasitic Infections |
| Key market players worldwide | Novartis AG ADR, Gilead Sciences Inc, GlaxoSmithKline, Johnson & Johnson, Roche Holding AG ADR, BioCryst Pharmaceuticals Inc, Merck & Co Inc, Boehringer Ingelheim |
Other key industry trends
- In terms of revenue, Canada accounted for 3.3% of the global infectious disease therapeutics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. infectious disease therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 2,936.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Disease Therapeutics Market Scope
Infectious Disease Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BioCryst Pharmaceuticals Inc | View profile | 531 | 4505 Emperor Boulevard, Suite 200, Durham, NC, United States, 27703 | https://www.biocryst.com |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Gilead Sciences Inc | View profile | 18000 | 333 Lakeside Drive, Foster, CA, United States, 94404 | https://www.gilead.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Canada infectious disease therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease therapeutics market will help companies and investors design strategic landscapes.
Viral infections was the largest segment with a revenue share of 40.04% in 2024. Horizon Databook has segmented the Canada infectious disease therapeutics market based on bacterial infections, viral infections, fungal infections, parasitic infections covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Canada infectious disease therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada infectious disease therapeutics market databook
-
Our clientele includes a mix of infectious disease therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada infectious disease therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Canada infectious disease therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada infectious disease therapeutics market size, by viral infections, 2018-2030 (US$M)
Canada Infectious Disease Therapeutics Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
